Pharma Nobis Freskaro refresh & revitalize Magnesium Recall

Why it was recalled

MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.

Product description

Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-312-10.

Lot numbers, UPCs & expiration codes

Lot A80622; Exp. 11/2025

Where it was sold

Nationwide.

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0231-2024
Classification: Class II
Status: Ongoing
Recall initiated: Dec 21, 2023
FDA report date: Jan 24, 2024
Quantity: 7,404 Bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Pharma Nobis LLC

Original FDA data

Every field from FDA enforcement report D-0231-2024, exactly as published.

Show all FDA fields

City: Texarkana
State: TX
Status: Ongoing
Country: United States
Event ID: 93682
Address: 7400 Alumax Rd
Code information: Lot A80622; Exp. 11/2025
Postal code: 75501-0282
Report date: Jan 24, 2024
Product type: Drugs
Recall number: D-0231-2024
Classification: Class II
Recalling firm: Pharma Nobis LLC
Product quantity: 7,404 Bottles
Reason for recall: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.
Voluntary / mandated: Voluntary: Firm initiated
Product description: Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-312-10.
Distribution pattern: Nationwide.
Recall initiation date: Dec 21, 2023
Initial firm notification: E-Mail
Center classification date: Jan 12, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0231-2024, published Jan 24, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.